Pfizer To Exit GSK's Consumer Health Arm After London Listing
ibtimes.com
news
2022-06-01 07:52:14

Pfizer plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK, after the business lists as an independent company in July, GSK said on Wednesday.GSK is spinning off Haleon, which makes Sensodyne toothpaste and Advil painkillers, so it can focus on disease prevention and treatment. GSK rejected a 50 billion pound ($63 billion) offer for Haleon last year, saying it undervalued the firm.Pfizer previously said it wanted to sell its shareholding in Haleon but GSK, which has a 68% controlling interest in the world's biggest consumer health business, had said in February the U.
